In MS, AD, FTD, and ALS, the onset of the clinical picture is associated with a spike in the increase of serum NfL that suggests the possibility of a flare in the ongoing pathophysiology, which associates with the appearance of clinical symptoms. The gene discussed is NEFL; the disease is amyotrophic lateral sclerosis.